Data / Drug companies / Metformin hydrochloride
Metformin hydrochloride: 79 companies and 376 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Metformin hydrochloride is listed in the FDA National Drug Code Directory by 79 companies, with 376 products in commercial distribution. 371 of the products (98.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, film coated; tablet, and the newest product started marketing on October 25, 2026.
The request: Get every company that lists metformin hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 79
- Products
- 376
- Generic (ANDA) products
- 371 (98.7%)
- Application numbers
- 47
- Routes
- Oral
- Brand names
- Glumetza
- openFDA record search
- api.fda.gov
Companies that list metformin hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 45 | tablet, film coated; tablet | Generic drugs (ANDA) | August 25, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 21 | tablet, extended release; tablet | Generic drugs (ANDA) | June 11, 2024 |
| Bryant Ranch Prepack | 20 | tablet, extended release; tablet | Generic drugs (ANDA) | March 29, 2024 |
| Remedyrepack Inc. | 16 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | October 25, 2026 |
| Preferred Pharmaceuticals Inc. | 15 | tablet; tablet, film coated | Generic drugs (ANDA) | August 27, 2026 |
| NuCare Pharmaceuticals,Inc. | 14 | tablet; tablet, film coated | Generic drugs (ANDA) | August 25, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 12 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | August 25, 2025 |
| Proficient Rx LP | 10 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | June 26, 2019 |
| Ascend Laboratories, LLC | 9 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | August 25, 2025 |
| Northwind Health Company, LLC | 9 | tablet, extended release; tablet | Generic drugs (ANDA) | December 30, 2025 |
| Westminster Pharmaceuticals, LLC | 8 | tablet, film coated; tablet, coated | Generic drugs (ANDA) | October 23, 2025 |
| Aurobindo Pharma Limited | 7 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | October 18, 2024 |
| Bryant Ranch Prepack | 6 | tablet; tablet, extended release | Generic drugs (ANDA) | August 6, 2020 |
| Coupler LLC | 6 | tablet; tablet, coated | Generic drugs (ANDA) | June 10, 2026 |
| Macleods Pharmaceuticals Limited | 6 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | March 13, 2024 |
| Chartwell RX, LLC | 5 | tablet | Generic drugs (ANDA) | January 24, 2002 |
| Direct_Rx | 5 | tablet; tablet, extended release | Generic drugs (ANDA) | June 1, 2021 |
| Epic Pharma, LLC | 5 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | July 8, 2020 |
| Granules Pharmaceuticals Inc. | 5 | tablet; tablet, extended release | Generic drugs (ANDA) | January 22, 2021 |
| Laurus Labs Limited | 5 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | October 6, 2023 |
| Marksans Pharma Limited | 5 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | May 12, 2016 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 5 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | March 29, 2024 |
| Precision Dose, Inc. | 5 | tablet, coated; tablet, extended release | Generic drugs (ANDA) | February 15, 2024 |
| ScieGen Pharmaceuticals, Inc. | 5 | tablet | Generic drugs (ANDA) | August 21, 2026 |
| Zydus Lifesciences Limited | 5 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | December 9, 2014 |
| Ajanta Pharma USA Inc. | 4 | tablet, extended release | Generic drugs (ANDA) | March 9, 2021 |
| Lupin Pharmaceuticals, Inc. | 4 | tablet, extended release | Generic drugs (ANDA) | February 1, 2016 |
| Quallent Pharmaceuticals Health LLC | 4 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | December 15, 2025 |
| Aci Healthcare USA, Inc. | 3 | tablet | Generic drugs (ANDA) | January 15, 2018 |
| American Health Packaging | 3 | tablet, film coated | Generic drugs (ANDA) | April 4, 2016 |
| Amneal Pharmaceuticals of New York LLC | 3 | tablet | Generic drugs (ANDA) | December 17, 2012 |
| Aurobindo Pharma Limited | 3 | tablet, film coated | Generic drugs (ANDA) | January 14, 2005 |
| Bryant Ranch Prepack | 3 | tablet; tablet, extended release | Generic drugs (ANDA) | August 6, 2020 |
| Golden State Medical Supply, Inc. | 3 | tablet | Generic drugs (ANDA) | September 11, 2013 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | January 19, 2023 |
| Legacy Pharmaceutical Packaging, LLC | 3 | tablet | Generic drugs (ANDA) | June 7, 2019 |
| Major Pharmaceuticals | 3 | tablet | Generic drugs (ANDA) | June 26, 2019 |
| Metcure Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | November 14, 2017 |
| Micro Labs Limited | 3 | tablet, film coated, extended release; solution | Generic drugs (ANDA) | March 1, 2023 |
| Mullan Pharmaceutical Inc. | 3 | tablet, coated | Generic drugs (ANDA) | January 1, 2024 |
| Mylan Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | June 3, 2010 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet; tablet, extended release | Generic drugs (ANDA) | May 12, 2016 |
| Proficient Rx LP | 3 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | August 25, 2025 |
| Proficient Rx LP | 3 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | March 1, 2013 |
| Puracap Laboratories LLC DBA Blu Pharmaceuticals | 3 | tablet, film coated | Generic drugs (ANDA) | April 1, 2016 |
| QPharma, Inc. | 3 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | August 25, 2025 |
| Santarus, Inc. | 3 | tablet, film coated, extended release | New drug applications (NDA) | March 20, 2018 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | December 9, 2014 |
| Amneal Pharmaceuticals LLC | 2 | tablet, extended release | Generic drugs (ANDA) | February 26, 2010 |
| Amneal Pharmaceuticals NY LLC | 2 | tablet, extended release | Generic drugs (ANDA) | February 26, 2010 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | September 11, 2013 |
| AvKARE | 2 | tablet, extended release | Generic drugs (ANDA) | June 11, 2024 |
| AvPAK | 2 | tablet, extended release | Generic drugs (ANDA) | May 2, 2022 |
| Glenmark Pharmaceuticals Inc., USA | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | November 25, 2019 |
| Granules India Limited | 2 | tablet, extended release | Generic drugs (ANDA) | February 1, 2021 |
| Lifsa Drugs LLC | 2 | tablet | Generic drugs (ANDA) | January 24, 2002 |
| Marlex Pharmaceuticals, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | September 1, 2026 |
| Method Pharmaceuticals, LLC | 2 | tablet | Generic drugs (ANDA) | February 9, 2026 |
| Oceanside Pharmaceuticals | 2 | tablet, film coated, extended release | Authorized generics (NDA) | March 20, 2018 |
| Redpharm Drug | 2 | tablet, extended release | Generic drugs (ANDA) | October 6, 2023 |
| Solco Healthcare US, LLC | 2 | tablet, extended release | Generic drugs (ANDA) | May 31, 2022 |
| Time Cap Laboratories, Inc | 2 | tablet, extended release | Generic drugs (ANDA) | May 12, 2016 |
| TruPharma, LLC | 2 | solution | Generic drugs (ANDA) | January 25, 2022 |
| Unichem Pharmaceuticals (USA), Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | August 11, 2021 |
| Unichem Pharmaceuticals (USA), Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | July 17, 2018 |
| Vgyaan Pharmaceuticals LLC | 2 | tablet, extended release | Generic drugs (ANDA) | November 30, 2021 |
| Viona Pharmaceuticals Inc | 2 | tablet, extended release | Generic drugs (ANDA) | March 15, 2019 |
| Advanced Rx of Tennessee, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | July 10, 2026 |
| Bionpharma Inc. | 1 | solution | Generic drugs (ANDA) | July 28, 2025 |
| Calvin Scott & Co., Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | June 8, 2017 |
| Camber Pharmaceuticals, Inc. | 1 | solution | Generic drugs (ANDA) | March 13, 2025 |
| Cardinal Health 107, LLC | 1 | tablet | Generic drugs (ANDA) | June 26, 2019 |
| Golden State Medical Supply, Inc. | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | December 26, 2017 |
| Leading Pharma, LLC | 1 | tablet, extended release | Generic drugs (ANDA) | May 1, 2025 |
| Saptalis Pharmaceuticals, LLC. | 1 | solution | Generic drugs (ANDA) | July 31, 2024 |
| Sun Pharmaceutical Industries, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | February 9, 2006 |
| Tagi Pharma, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | April 17, 2008 |
| Unit Dose Solutions, Inc. | 1 | tablet | Generic drugs (ANDA) | June 26, 2026 |
| VistaPharm, LLC | 1 | solution | Generic drugs (ANDA) | December 19, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 138 | 36.7% |
| Tablet, film coated | 103 | 27.4% |
| Tablet | 100 | 26.6% |
| Tablet, coated | 16 | 4.3% |
| Tablet, film coated, extended release | 12 | 3.2% |
| Solution | 7 | 1.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 371 | 98.7% |
| New drug applications (NDA) | 3 | 0.8% |
| Authorized generics (NDA) | 2 | 0.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Biguanide | 376 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.